Abstract Major Depressive Disorder (MDD) is common among cancer patients, with
prevalence rates up to four-times higher than the general population. Depression confers …

Depression and cancer commonly co-occur. The prevalence of depression among cancer
patients increases with disease severity and symptoms such as pain and fatigue. The …

Innate immune activation and inflammation have been posited to play a role in the
pathophysiology of both depression and neoplastic growth. Cancer patients experience a …

Depression is a common comorbidity in cancer cases, affecting> 10% of patients. A cancer
diagnosis is life‑changing, and is a source of considerable psychological and emotional …

Patients with cancer are more likely to develop depression than the general population,
which negatively impacts their quality of life and prognosis. In order to identify effective …

Considerable data demonstrate the high prevalence of symptoms of depression in patients
with a wide variety of neoplastic disorders. Moreover, the dire consequences of these …

Cancer patients experience several stressors and emotional upheavals. Fear of death,
interruption of life plans, changes in body image and self-esteem, changes in social role and …

The present article reviews recent literature on depression and cancer and highlights
practical assessment and detection of depression, biological and physiopathological …

The prevalence of depressive symptoms in patients with cancer exceeds that observed in
the general population and depression is associated with a poorer prognosis in cancer …

BACKGROUND Head and neck cancers are associated with high rates of depression, which
may increase the risk for poorer immediate and long‐term outcomes. Here it was …